Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S 44819 in post-ischemic stroke recovery
NCT02877615Phase 2Completed
- Sponsor
- Servier
- Start
- Dec 2016
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 2 trial of S44819 in ischemic stroke, sponsored by Servier. Started Dec 2016; status: completed.
02
Drugs
S44819
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02877615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02877615.